Repligen Corp. (RGEN)

131.21 +4.12 (+3.24%) USD  |  NASDAQ  |  Apr 17, 16:00
130.48 -0.73 (-0.56%) After-Hours: 06:07
More

Repligen Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Masimo Corp. Upgrade
Orthofix Medical, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade